Amarantus Biosci (AMBS) Financial Statements
Amarantus Biosci Financial Overview
Amarantus Biosci's market cap is currently $630. The company's EPS TTM is $-0.00; its P/E ratio is -0.01; Amarantus Biosci has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 95.33K | $ 0.00 | $ 74.70K | $ 20.00M | $ 0.00 |
| Gross Profit | $ 95.33K | $ 0.00 | $ 74.70K | $ 20.00M | $ 0.00 |
| Operating Income | $ -268.00K | $ -148.00K | $ -628.00K | $ 18.33M | $ -3.04M |
| EBITDA | $ -4.53M | $ -9.96M | $ -421.70K | $ 18.55M | $ -66.00 |
| Net Income | $ -4.76M | $ -10.20M | $ -628.00K | $ 18.38M | $ -10.58M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 0.00 | $ 708.00 | $ 46.00 | $ 708.00 | $ 829.00 |
| Total Assets | $ 10.21M | $ 14.71M | $ 24.87M | $ 24.79M | $ 3.48M |
| Total Debt | $ 19.14M | $ 19.19M | $ 19.20M | $ 19.14M | $ 18.66M |
| Net Debt | $ 19.14M | $ 19.19M | $ 19.20M | $ 19.14M | $ 18.65M |
| Total Liabilities | $ 34.87M | $ 34.63M | $ 34.36M | $ 33.74M | $ 31.39M |
| Stockholders' Equity | $ -24.67M | $ -19.93M | $ -9.48M | $ -8.96M | $ -27.90M |
| Cash Flow | |||||
| Free Cash Flow | $ -4.50M | $ -9.93M | $ -82.66K | $ 1.02M | $ -1.80M |
| Operating Cash Flow | $ -4.50M | $ -9.93M | $ -82.66K | $ 1.02M | $ -1.80M |
| Investing Cash Flow | $ 4.50M | $ 9.97M | $ -81.25K | $ -2.03M | $ 6.07M |
| Financing Cash Flow | $ 0.00 | $ -45.39K | $ 163.25K | $ 1.01M | $ -4.33M |
Currency in USD